To determine how LSD1 inhibition altered response to targeted therapy, we implanted HT29 cells orthotopically into the colons of NSG mice and, following tumor formation, treated the mice with vehicle or BRAFi + EGFRi with or without the LSD1i SP-2577. The gene discussed is KDM1A; the disease is neoplasm.